ArticleCancer communications (London, England)2022

JUPITER-02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps.

Laura Ling Ying Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.